FDA Approves High-Dose Spinraza for SMA Patients
The FDA has approved a new high-dose regimen of Spinraza, giving people with spinal muscular atrophy a more effective treatment option with better outcomes. After a decade of proven results, this milestone brings hope to thousands of families fighting SMA.